Acquisitions (Details) $ in Thousands, SFr in Millions |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Oct. 31, 2025
USD ($)
|
Oct. 31, 2025
CHF (SFr)
|
Jan. 31, 2025
USD ($)
|
Jan. 31, 2025
CHF (SFr)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2025
CHF (SFr)
|
|
| Business Combination [Line Items] | ||||||||||
| Acquired in-process research and development expenses | $ 0 | $ 0 | $ 0 | $ 75,217 | ||||||
| AMF Medical Acquisition | ||||||||||
| Business Combination [Line Items] | ||||||||||
| Payments of cash | SFr | SFr 68.0 | |||||||||
| Price of acquisition, expected | $ 35,100 | SFr 28.0 | $ 43,500 | SFr 40.0 | ||||||
| Acquired in-process research and development expenses | $ 75,200 | SFr 68.0 | ||||||||
| Foreign exchange losses | $ 3,400 | |||||||||
| X | ||||||||||
- Definition Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both. Includes, but is not limited to, software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|